The New Normal: Dr. Ihor Sawczuk, Dr. Bruce Farber talk vaccine trials, promising Moderna news
As cases of COVID-19 continue to rise across the country, we got another good piece of news this week, with Moderna seeing 94% effectiveness in its vaccine thus far.
•
Nov 17, 2020, 2:31 AM
•
Updated 1,489 days ago
Share:
More Stories
Hometown Heroes in New York City
144ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
440ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
451ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
458ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
472ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
473ds agoHometown Heroes in New York City
144ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
440ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
451ds ago1:54
Hochul: Updated COVID vaccine to be available in NY in the coming days
458ds ago2:22
New and rare COVID variant detected in NYC wastewater; Gov. Hochul urges caution
472ds ago2:39
City health officials: COVID-19 cases on the rise as new variant emerges
473ds agoAs cases of COVID-19 continue to rise across the country, we got another good piece of news this week, with Moderna seeing 94% effectiveness in its vaccine thus far.
We're joined by Dr. Bruce Farber, Dr. Ihor Sawczuk, a Long Island COVID-19 survivor and more in this week's New Normal special.
Here are some highlights from the special.
Two straight Mondays with big vaccine news - here's Dr. Farber's reaction:
Messenger RNA has been a point of conversation in these trials. Farber explains why it's a great development:
One of the big developments from Moderna's trials is the difference in temperature it can be stored at. Here's what that means:
Why be part of the COVID-19 vaccine trials? Hackensack Meridian Health's Dr. Ihor Sawczuk tells us about his thought process:
Sawczuk also talked about the importance of having sizable, diverse demographics in the trials:
More from News 12
1:32
8 tips for working safely during hot weather
3:31
Guide: Ways to set your child up for financial success
3:18
Guide: The importance of good sleep and how to get it
Guide: Mental health resources available in the tri-state
9:36
3 ways to prevent parental burnout
1:02
